Recent advances in the genetics of hereditary axonal sensory-motor neuropathies type 2

Current Neurology and Neuroscience Reports

Volumn 11, Issue 3, 2011, Pages 262-273

  Ajroud Driss, Senda ^a,b   Deng, Han Xiang ^a   Siddique, Teepu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Axonal CMT; Axonal transport; CMT2; CMT2A1; CMT2A2; CMT2B; CMT2B1; CMT2B2; CMT2C; CMT2D; CMT2G; CMT2I; CMT2J; CMT2K; CMT2L; CMT2M; CMT2N; CMTF; CMTH; Endosomal trafficking; HSMN; Mitochondrial dynamic; RNA processing

Indexed keywords

ALANINE TRANSFER RNA LIGASE; DYNAMIN II; GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 1; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN B8; KINESIN 1; KINESIN 1B; LAMININ A; MEDIATOR COMPLEX SUBUNIT 25; MEMBRANE PROTEIN; MITOFUSIN 2; MYELIN PROTEIN; MYELIN PROTEIN ZERO; NEUROFILAMENT LIGHT CHAIN PROTEIN; NEUROFILAMENT PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4;

ALANYL TRNA SYNTHETASE GENE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CHARCOT MARIE TOOTH DISEASE TYPE 2; CLINICAL FEATURE; DYNAMIN 2 GENE; GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 1 GENE; GENE; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; GLYCYL TRNA SYNTHETASE GENE; HEAT SHOCK PROTEIN 27 B1 GENE; HEAT SHOCK PROTEIN B8 GENE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; KINESIN FAMILY MEMBER 1B GENE; LAMININ A GENE; MEDIATOR COMPLEX SUBUNIT 25 GENE; MITOFUSIN 2 GENE; MOLECULAR GENETICS; MOTOR NERVE CONDUCTION; MYELIN PROTEIN ZERO GENE; NEUROFILAMENT LIGHT CHAIN GENE; NONHUMAN; PHENOTYPIC VARIATION; RAS ASSOCIATED PROTEIN RAB7 GENE; VANILLOID RECEPTOR 4 GENE; GENETIC LINKAGE; GENETICS; NEUROPATHY; PHENOTYPE; REVIEW;

CHARCOT-MARIE-TOOTH DISEASE; GENETIC LINKAGE; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; PHENOTYPE;

EID: 79961163495     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0185-z     Document Type: Article

References (95)

1. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62:310-8. (Pubitemid 27199100)
2. Bienfait HM, Baas F, Koelman JH, et al. Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology. 2007;68:1658-67. (Pubitemid 46763252)
3. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell. 2001;105:587-97. (Pubitemid 32524112)
4. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36:449-51. (Pubitemid 38620027)
5. Chen H, Chan DC: Physiological functions of mitochondrial fusion. Ann N Y Acad Sci. 2010;1201: 21-5.
6. Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005;280:26185-92. (Pubitemid 41022214)
7. Misko A, Jiang S, Wegorzewska I, et al.: Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci. 2010;30: 4232-40.
8. Cartoni R, Arnaud E, Medard JJ, et al.: Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A. Brain 2010;133: 1460-9.
9. Lawson VH, Graham BV, Flanigan KM. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology. 2005;65:197-204. (Pubitemid 41022361)
10. Zhu D, Kennerson ML, Walizada G, et al. Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Neurology. 2005;65:496-7. (Pubitemid 41099829)
11. Ajroud-Driss S, Fecto F, Ajroud K, et al. A novel de novo MFN2 mutation causing CMT2A with upper motor neuron signs. Neurogenetics. 2009;10:359-61.
12. Zuchner S, De Jonghe P, Jordanova A, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol. 2006;59:276-81. (Pubitemid 43202480)
13. Chung KW, Kim SB, Park KD, et al. Early onset severe and lateonset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain. 2006;129:2103-18. (Pubitemid 44289075)
14. Kwon JM, Elliott JL, Yee WC, et al. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet. 1995;57:853-8.
15. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet. 2003;72:722-7. (Pubitemid 36255971)
16. Grosshans BL, Ortiz D, Novick P. Rabs and their effectors: achieving specificity in membrane traffic. Proc Natl Acad Sci USA. 2006;103:11821-7. (Pubitemid 44215770)
17. Bucci C, Bakke O, Progida C. Rab7b and receptors trafficking. Commun Integr Biol. 2010;3:401-4.
18. Deinhardt K, Salinas S, Verastegui C, et al. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron. 2006;52:293-305. (Pubitemid 44548343)
19. Cogli L, Progida C, Lecci R, et al.: CMT2B-associated Rab7 mutants inhibit neurite outgrowth. Acta Neuropathol. 2010;120: 491-501.
20. Yamauchi J, Torii T, Kusakawa S, et al.: The mood stabilizer valproic acid improves defective neurite formation caused by charcot-marie-tooth disease-associated mutant Rab7 through the JNK signaling pathway. J Neurosci Res. 2010;88: 3189-97.
21. DeLong R, Siddique T. A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features. Arch Neurol. 1992;49:905-8.
22. Isozumi K, DeLong R, Kaplan J, et al. Linkage of scapuloperoneal spinal muscular atrophy to chromosome 12q24.1-q24.31. Hum Mol Genet. 1996;5:1377-82. (Pubitemid 26335859)
23. Dyck PJ, Litchy WJ, Minnerath S, et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol. 1994;35:608-15. (Pubitemid 24153845)
24. Klein CJ, Cunningham JM, Atkinson EJ, et al. The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology. 2003;60:1151-6. (Pubitemid 36418777)
25. McEntagart ME, Reid SL, Irrthum A, et al. Confirmation of a hereditary motor and sensory neuropathy IIC locus at chromosome 12q23-q24. Ann Neurol. 2005;57:293-7. (Pubitemid 40179869)
26. Deng HX, Klein CJ, Yan J, et al.: Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet. 2010;42: 165-9.
27. Auer-Grumbach M, Olschewski A, Papic L, et al.: Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet. 2010;42: 160-164.
28. Landoure G, Zdebik AA, Martinez TL, et al.: Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet. 2010;42: 170-4.
29. Auer-Grumbach M, De Jonghe P, Wagner K, et al. Phenotypegenotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology. 2000;55:1552-7.
30. Strotmann R, Harteneck C, Nunnenmacher K, et al. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol. 2000;2:695-702.
31. Nilius B, Owsianik G: Channelopathies converge on TRPV4. Nat Genet. 2010;42: 98-100.
32. Klein CJ, Shi Y, Fecto F, et al.: Mutations and cytotoxic hypercalcemia in axonal Charcot-Matie-Tooth neuropathies. Neurology In Press.
33. Zimon M, Baets J, Auer-Grumbach M, et al. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain. 2010;133:1798-809.
34. Rock MJ, Prenen J, Funari VA, et al. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet. 2008;40:999-1003.
35. Krakow D, Vriens J, Camacho N, et al. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am J Hum Genet. 2009;84:307-15.
36. Wang Y, Fu X, Gaiser S, et al. OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum. J Biol Chem. 2007;282:36561-70.
37. Liedtke W, Friedman JM. Abnormal osmotic regulation in trpv4-/-mice. Proc Natl Acad Sci USA. 2003;100:13698-703.
38. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem. 2003;278:22664-8. (Pubitemid 36830325)
39. Gevaert T, Vriens J, Segal A, et al. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest. 2007;117:3453-62. (Pubitemid 350097001)
40. Ionasescu V, Searby C, Sheffield VC, et al. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet. 1996;5:1373-5. (Pubitemid 26335858)
41. Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet. 2003;72:1293-9. (Pubitemid 36530017)
42. Chihara T, Luginbuhl D, Luo L. Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization. Nat Neurosci. 2007;10:828-37. (Pubitemid 47013428)
43. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet. 2000;67:37-46. (Pubitemid 30481542)
44. Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, et al. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene. Arch Neurol. 2007;64:966-70. (Pubitemid 47047996)
45. Fabrizi GM, Cavallaro T, Angiari C, et al. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology. 2004;62:1429-31. (Pubitemid 38526066)
46. Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol. 2004;58:131-48. (Pubitemid 37543344)
47. Perez-Olle R, Jones ST, Liem RK. Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum Mol Genet. 2004;13:2207-20. (Pubitemid 39359921)
48. Dequen F, Filali M, Lariviere RC, et al.: Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E. Hum Mol Genet. 2010;19: 2616-29.
49. Ismailov SM, Fedotov VP, Dadali EL, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur J Hum Genet. 2001;9:646-50. (Pubitemid 32776383)
50. Evgrafov OV, Mersiyanova I, Irobi J, et al. Mutant small heatshock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet. 2004;36:602-6. (Pubitemid 38715987)
51. Solla P, Vannelli A, Bolino A, et al.: Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy. J Neurol Neurosurg Psychiatry 2010;81: 958-62.
52. Garrido C, Brunet M, Didelot C, et al. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5:2592-601. (Pubitemid 44785803)
53. Ackerley S, James PA, Kalli A, et al. A mutation in the small heatshock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet. 2006;15:347-54. (Pubitemid 43125988)
54. Zhai J, Lin H, Julien JP, Schlaepfer WW. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1. Hum Mol Genet. 2007;16:3103-16. (Pubitemid 350131329)
55. Almeida-Souza L, Goethals S, de Winter V, et al. Increased monomerization of mutant HSPB1 leads to protein hyperactivity in Charcot-Marie-Tooth neuropathy. J Biol Chem. 2010;285:12778-86.
56. Nelis E, Berciano J, Verpoorten N, et al. Autosomal dominant axonal Charcot-Marie-Tooth disease type 2 (CMT2G) maps to chromosome 12q12-q13.3. J Med Genet. 2004;41:193-7. (Pubitemid 38333797)
57. Hayasaka K, Himoro M, Sato W, et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet. 1993;5:31-4. (Pubitemid 23261514)
58. Shy ME, Jani A, Krajewski K, et al. Phenotypic clustering in MPZ mutations. Brain. 2004;127:371-84. (Pubitemid 38160322)
59. De Jonghe P, Timmerman V, Ceuterick C, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain. 1999;122(Pt 2):281-90. (Pubitemid 29067210)
60. Nakamura N, Kawamura N, Tateishi T, et al. Predominant parasympathetic involvement in a patient with Charcot-Marie-Tooth disease caused by the MPZ Thr124Met mutation. Rinsho Shinkeigaku. 2009;49:582-5.
61. Spiryda LB, Colman DR. Protein zero, a myelin IgCAM, induces physiologically operative tight junctions in nonadhesive carcinoma cells. J Neurosci Res. 1998;54:282-8. (Pubitemid 28469069)
62. Martini R, Zielasek J, Toyka KV, et al. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet. 1995;11:281-6.
63. Shy ME. Peripheral neuropathies caused by mutations in the myelin protein zero. J Neurol Sci. 2006;242:55-66.
64. Mandich P, Fossa P, Capponi S, et al.: Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies. Eur J Hum Genet. 2009;17: 1129-34.
65. Barhoumi C, Amouri R, Ben Hamida C, et al. Linkage of a new locus for autosomal recessive axonal form of Charcot-Marie-Tooth disease to chromosome 8q21.3. Neuromuscul Disord. 2001;11:27-34. (Pubitemid 32106879)
66. Claramunt R, Pedrola L, Sevilla T, et al. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet. 2005;42:358-65. (Pubitemid 40523959)
67. Crimella C, Tonelli A, Airoldi G, et al.: The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2 K. J Med Genet. 2010;47: 712-6.
68. Sevilla T, Jaijo T, Nauffal D, et al.: Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy. Brain 2008;131: 3051-61.
69. Baxter RV, Ben Othmane K, Rochelle JM, et al. Gangliosideinduced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet. 2002;30:21-2.
70. Niemann A, Ruegg M, La Padula V, et al. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol. 2005;170:1067-78. (Pubitemid 41362639)
71. Niemann A, Wagner KM, RueggM, Suter U. GDAP1mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol Dis. 2009;36:509-20.
72. Tang BS, Luo W, Xia K, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet. 2004;114:527-33. (Pubitemid 39010849)
73. Tang BS, Zhao GH, Luo W, et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet. 2005;116:222-4. (Pubitemid 40174008)
74. Irobi J, De Jonghe P, Timmerman V. Molecular genetics of distal hereditary motor neuropathies. Hum Mol Genet. 2004;13(Spec No 2):R195-202. (Pubitemid 39359903)
75. Carra S, Sivilotti M, Chavez Zobel AT, et al. HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet. 2005;14:1659-69. (Pubitemid 40895518)
76. Irobi J, Almeida-Souza L, Asselbergh B, et al.: Mutant HSPB8 causes motor neuron-specific neurite degeneration. Hum Mol Genet. 2010;19: 3254-65.
77. Zuchner S, Noureddine M, Kennerson M, et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet. 2005;37:289-94. (Pubitemid 41716256)
78. Claeys KG, Zuchner S, Kennerson M, et al. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain. 2009;132:1741-52.
79. Bitoun M, Maugenre S, Jeannet PY, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37:1207-9. (Pubitemid 41568701)
80. Fabrizi GM, Ferrarini M, Cavallaro T, et al. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology. 2007;69:291-5. (Pubitemid 47205692)
81. Hinshaw JE. Dynamin and its role in membrane fission. Annu Rev Cell Dev Biol. 2000;16:483-519. (Pubitemid 32037515)
82. Durieux AC, Prudhon B, Guicheney P, Bitoun M: Dynamin 2 and human diseases. J Mol Med. 2010;88: 339-50.
83. Latour P, Thauvin-Robinet C, Baudelet-Mery C, et al.: A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet. 2010;86: 77-82.
84. JordanovaA, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet. 2006;38:197-202. (Pubitemid 43177233)
85. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 2002;70:726-36. (Pubitemid 34177926)
86. Bouhouche A, Benomar A, Birouk N, et al. A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21.2-q21.3. Am J Hum Genet. 1999;65:722-7. (Pubitemid 30468716)
87. Bouhouche A, Birouk N, Azzedine H, et al. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families. Brain. 2007;130:1062-75. (Pubitemid 47355597)
88. Hamadouche T, Poitelon Y, Genin E, et al. Founder effect and estimation of the age of the c.892 C>T (p.Arg298Cys) mutation in LMNA associated to Charcot-Marie-Tooth subtype CMT2B1 in families from NorthWestern Africa. Ann Hum Genet. 2008;72:590-7.
89. Chaouch M, Allal Y, De Sandre-Giovannoli A, et al. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul Disord. 2003;13:60-7. (Pubitemid 35430141)
90. Tazir M, Azzedine H, Assami S, et al. Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C. Brain. 2004;127:154-63. (Pubitemid 38055354)
91. Bernard R, De Sandre-Giovannoli A, Delague V, Levy N. Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies. Neuromolecular Med. 2006;8:87-106.
92. Leal A, Morera B, Del Valle G, et al. A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3. Am J Hum Genet. 2001;68:269-74. (Pubitemid 32048386)
93. Berghoff C, Berghoff M, Leal A, et al. Clinical and electrophysiological characteristics of autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2B) that maps to chromosome 19q13.3. Neuromuscul Disord. 2004;14:301-6. (Pubitemid 38507403)
94. Leal A, Huehne K, Bauer F, et al.: Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics 2009, 10:275-87.
95. Lupski JR, Reid JG, Gonzaga-Jauregui C, et al.: Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med. 2010, 362:1181-91.